Voll-Aanerud, M., Eagan, T. M., Wentzel-Larsen, T., Gulsvik, A. & Bakke, P. S. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir. Med. 102(3), 399–406 (2008).
Stavem, K., Johannessen, A., Nielsen, R. & Gulsvik, A. Respiratory symptoms and respiratory deaths: A multi-cohort study with 45 years observation time. PLoS One 16(11), e0260416 (2021).
Gulsvik, A. Prevalence of respiratory symptoms in the city of Oslo. Scand. J. Respir. Dis. 60(5), 275–285 (1979).
Gulsvik, A., Bakke, P. S., Brøgger, J., Nielsen, R. & Stavem, K. Respiratory symptoms and mortality in four general population cohorts over 45 years. Respir. Med. 170, 106060 (2020).
Voll-Aanerud, M. et al. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: Results from the European community respiratory health survey. Health Qual. Life Outcomes 8, 107. doi.org/10.1186/1477-7525-8-107 (2010).
Jin, J. JAMA patient page. Medications for weight loss: Indications and usage. JAMA 313(21), 2196 (2015).
Ikramuddin, S. et al. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: The ReCharge randomized clinical trial. JAMA 312, 915–922 (2014).
Frostad, A., Soyseth, V., Haldorsen, T., Andersen, A. & Gulsvik, A. Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia. Thorax 61(11), 951–956 (2006).
Yang, L. & Colditz, G. A. Prevalence of Overweight and Obesity in the United States, 2007–2012. JAMA Intern Med. 175(8), 1412–1413 (2015).
Beuther, D. A. & Sutherland, E. R. Overweight, obesity, and incident asthma: A meta-analysis of prospective epidemiologic studies. Am. J. Respir. Crit. Care Med. 175(7), 661–666 (2007).
Bastard, J. P. et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85(9), 3338–3342 (2000).
Roth, C. L., Kratz, M., Ralston, M. M. & Reinehr, T. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism 60(4), 445–452 (2011).
Giri Ravindran, S. et al. The obesity paradox in chronic heart disease and chronic obstructive pulmonary disease. Cureus 14(6), e25674 (2022).
Stephenson, H., Roberts, M., Klimkeit, E. & Smith, T. Uncovering undernutrition in chronic obstructive pulmonary disease: Beyond body mass index. Respir. Med. 205, 107026. doi.org/10.1016/j.rmed.2022.107026 (2022).
Chen, T. C. et al. National Health and Nutrition Examination Survey: Estimation Procedures, 2011–2014. Vital Health Stat. 2(177), 1–26 (2018).
National Center for Health Statistics. NCHS Research Ethics Review Board (ERB) Approval. 2017 [14/06/2022]; www.cdc.gov/nchs/nhanes/irba98.htm.
Bhaskaran, K., Dos-Santos-Silva, I., Leon, D. A., Douglas, I. J. & Smeeth, L. Association of BMI with overall and cause-specific mortality: A population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 6(12), 944–953. doi.org/10.1016/S2213-8587(18)30288-2 (2018).
Marcus, B. S., McAvay, G., Gill, T. M. & Vaz Fragoso, C. A. Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons. J. Am. Geriatr. Soc. 63(2), 251–257 (2015).
Celli, B. R. Predictors of mortality in COPD. Respir. Med. 104(6), 773–779 (2010).
Jubber, A. S. Respiratory complications of obesity. Int. J. Clin. Pract. 58(6), 573–580 (2004).
Sutherland, E. R. Linking obesity and asthma. Ann. N. Y. Acad. Sci. 1311, 31–41 (2014).
Littleton, S. W. & Tulaimat, A. The effects of obesity on lung volumes and oxygenation. Respir. Med. 124, 15–20 (2017).
Castro-Añón, O. et al. Obesity-hypoventilation syndrome: Increased risk of death over sleep apnea syndrome. PLoS One 10, 0117808 (2015).
Schachter, L. M. et al. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax 56(1), 4–8 (2001).
Landt, E. M., Çolak, Y., Nordestgaard, B. G., Lange, P. & Dahl, M. Risk and impact of chronic cough in obese individuals from the general population. Thorax 77(3), 223–230 (2022).
Casas-Vara, A. et al. The obesity paradox in elderly patients with heart failure: Analysis of nutritional status. Nutrition 28(6), 616–622 (2012).
Lambert, A. A. et al. Obesity is associated with increased morbidity in moderate to severe COPD. Chest 151, 68–77 (2017).
Kim, E. K. et al. Impact of body mass index change on the prognosis of chronic obstructive pulmonary disease. Respiration 99, 943–953 (2020).
Kumanyika, S. K., Whitt-Glover, M. C. & Haire-Joshu, D. What works for obesity prevention and treatment in black Americans? Research directions. Obes. Rev. 15(Suppl 4), 204–212. doi.org/10.1111/obr.12213 (2014).
Dominguez, K. et al. Vital signs: Leading causes of death, prevalence of disease and risk factors, and use of health services among Hispanics in the United States-2009–2013. Morb. Mortal Wkly Rep. 64, 469–478 (2015).
Flegal, K. M. et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307, 491–497 (2012).
Fisher-Hoch, S. P. et al. Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004–2007. Prev. Chron. Dis. 7, A53 (2010).
Barondess, D. A., Nelson, D. A. & Schlaen, S. E. Whole body bone, fat, and lean mass in black and white men. J. Bone Miner. Res. 12(6), 967–971. doi.org/10.1359/jbmr.1997.12.6.967 (1997).
Huisman, H. W., Schutte, R., Venter, H. L. & van Rooyen, J. M. Low BMI is inversely associated with arterial stiffness in Africans. Brit. J. Nutr. 113(10), 1621–1627 (2015).
Yates, W. R., Johnson, C., McKee, P. & Cannon-Albright, L. A. Genetic analysis of low BMI phenotype in the Utah Population Database. PLoS One 8(12), e80287 (2013).
Prospective Studies Collaboration et al. Body-mass index and cause-specific mortality in 900,000 adults: Collaborative analyses of 57 prospective studies. Lancet 373(9669), 1083–1096 (2009).
Lopez-Jimenez, F. Speakable and unspeakable facts about BMI and mortality. Lancet 373, 1055–1056 (2009).
Grigsby, M. R. et al. Low body mass index is associated with higher odds of COPD and lower lung function in low- and middle-income countries. COPD 16(1), 58–65 (2019).
